Cannabis Pot-Folio Peek: Zuanic Breaks Down Reports On Verano, TILT, MariMed And Green Thumb

In a series of recent reports, Zuanic & Associates scrutinizes Verano Holdings, TILT Holdings, MariMed Inc., and Green Thumb Industries, providing essential insights into their current status and future outlook within the cannabis market.

Verano Holdings

• According to senior analyst Pablo Zuanic, Verano Holdings' VRNOF outlook post-3Q results anticipates a decline in 4Q due to seasonality, pricing factors and market adjustments.
• Despite potential margin pressures, forward-looking free cash flow guidance suggests positive trends. The reports primarily serve consensus compilation purposes, encouraging reference to the initiation reports for comprehensive stock analysis.

TILT Holdings

• TILT Holdings TLLTF reports exceeded expectations in 3Q sales and EBITDA, positioning the company for future growth in CY24.
• Although 4Q is viewed as a transitional period, Zuanic noted the company remains well-positioned for expansion with Jupiter regaining market share and new brand partnerships strengthening both divisions.

MariMed Inc.

• MariMed Inc. MRMD faces a reduction in 4Q guidance, primarily attributed to timing-related issues in expansion projects. However, the company's diverse expansion initiatives across multiple states forecast positive prospects for CY24.
• Zuanic takes note of the unjustified valuation discount, citing expansion levers and attaching updated estimates.

Green Thumb 

• Green Thumb Industries GTBIF post-3Q update reveals an absence of sales guidance for 4Q with management signaling flat sales trends. Recent capital expenditure increases are seen as favorable for 1H24 top-line growth.

Photo by Steve Johnson on Unsplash.